TOP STORIES

• BUSINESS Takeda Attracted to Shire’s High Profitability, Rare Disease Pipeline: CEO
  May 9, 2018

• BUSINESS Takeda Cuts Deal to Acquire Shire in Japan’s Biggest Buyout
  May 8, 2018

• BUSINESS Over 60% of Drug Makers Cut New Grad Hires in FY2018, Otsuka Tops List Again: Tally
  May 8, 2018

• BUSINESS Competition Heating Up for HIF-PH Inhibitors; Astellas Expected to Be First with Filing Likely in FY2018
  May 7, 2018

• BUSINESS Japan to Join Jardiance Study for CKD under Collaboration between Boehringer, Lilly, and Oxford
  May 2, 2018

• BUSINESS Olmetec Sales Nosedive 67.8% in North America in FY2017: Daiichi Sankyo
  May 1, 2018

• BUSINESS Bayer Japan Chief “Disappointed” at PMP Removal for Xarelto, Shows Eagerness for Add’l Indications
  April 27, 2018

• REGULATORY Imfinzi Sails through MHLW Panel, Now in Line for Stage III NSCLC Nod
  April 26, 2018

• ORGANIZATION PhRMA/EFPIA Say Humira, Jevtana, Xarelto Lost Eligibility under New PMP, Innovation Not Appropriately Defined
  April 26, 2018

• BUSINESS Takeda, Shire Reach Preliminary Deal, Extend Takeover Deadline to May 8
  April 25, 2018

• BUSINESS Takeda Makes Fifth Pitch for Shire Buyout as Deadline Looms
  April 25, 2018

• BUSINESS Novartis Seeks Japan Approval for Kymriah, Will Outcome-Based Model Be Put in Place?
  April 24, 2018

• ACADEMIA Clinical Trials for Mitochondrial Disease Heating Up with AMED’s Support; Filing for First Hyperlactacidemia Drug Expected in 2020
  April 23, 2018

• BUSINESS Takeda Sweetens Bid for Shire, Ups Cash Component
  April 23, 2018

• BUSINESS Takeda in Talks with Shire after 3 Buyout Proposals Rejected
  April 20, 2018

• TRENDS Industry Group Anticipates New Demand for Contract Reps after Current Phase of Downsizing by Drug Makers
  April 20, 2018

• BUSINESS Tecentriq Now in PD-1/L1 NSCLC Showdown, Lynparza Also Hits Japan Market
  April 19, 2018

• ACADEMIA Physicians Association Initiates Large-Scale Study to Directly Compare DPP-4 Inhibitors to SGLT2 Inhibitors, Determine “Optimal Patients” for Each
  April 19, 2018

• BUSINESS Another Huge Seller Re-Pricing Won’t Hit Opdivo Unless 195 Billion Yen Sales Reached: Ono Chief
  April 18, 2018

• BUSINESS Sumitomo Dainippon Reorganizes Drug Discovery Research System; Accelerating Decision-Making: Pres.
  April 18, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 141
• 142
• 143
• 144
• 145
• 146
• 147
• 148
• 149
• …
• Next ›
• 最終 »